247
Views
7
CrossRef citations to date
0
Altmetric
ONCOLOGY

Investigation strategy in the management of metastatic adenocarcinoma of unknown primary presenting as cervical lymphadenopathy

, , , , , & show all
Pages 838-842 | Received 27 Nov 2013, Accepted 09 Jan 2014, Published online: 22 May 2014

References

  • Calabrese L, Jereczek-Fossa BA, Jassem J, Rocca A, Bruschini R, Orecchia R, et al. Diagnosis and management of neck metastases from an unknown primary. Acta Otorhinolaryngol Ital 2005;25:2–12.
  • Jesse RH, Neff LE. Metastatic carcinoma in cervical nodes with an unknown primary lesion. Am J Surg 1966;112:547–53.
  • Barrie JR, Knapper WH, Strong EW. Cervical nodal metastases of unknown origin. Am J Surg 1970;120:466–70.
  • Glynne-Jones RGT, Anand AK, Young TE, Berry RJ. Metastatic adenocarcinoma in the cervical lymph nodes from an occult primary. Clin Oncol 1989;1:19–21.
  • Lee NK, Byers RM, Abbruzzese JL, Wolf P. Metastatic adenocarcinoma to the neck from an unknown primary source. Am J Surg 1991;162:306–9.
  • Zuur CL, van Velthuysen ML, Schornagel JH, Hilgers FJ, Balm AJ. Diagnosis and treatment of isolated neck metastases of adenocarcinomas. Eur J Surg Oncol 2002;28:147–52.
  • Jones AS, Phillips DE, Field JK, Gati I. Non-squamous malignancy in lymph nodes: the occult primary. Clin Otolaryngol Allied Sci 1993;18:311–16.
  • Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 2011;52:1914–22.
  • Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg 2009;135:1024–9.
  • Assar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumours. Radiology 1999;210:177–81.
  • Jungehulsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, et al. 2(F)-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000;123:294–301.
  • Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumours. Oral Oncol 2009;45:218–24.
  • Xu G, Li J, Zuo X, Li C. Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis. Laryngoscope 2012;122:1974–8.
  • Arunachalam PS, Putnam G, Jennings P, Messersmith R, Robson AK. Role of computerized tomography (CT) scan of the chest in patients with newly diagnosed head and neck cancers. Clin Otolaryngol Allied Sci 2002;27:409–11.
  • Chalmers N, Best JJ. The significance of pulmonary nodules detected by CT but not by chest radiography in tumour staging. Clin Radiol 1991;44:410–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.